bluuebunny/crossref_metadata_2025_split huggingface dataset:
Evaluation of HBV Reactivation and Antiviral Prophylaxis in Patients Receiving Immunosuppressive Therapy
Authors: ŞAHİN Ahmet , ASLAN Selda 
Published: October 2023

Aim: Patients with chronic hepatitis B and people with a history of hepatitis B (HBV) infection are at risk of HBV reactivation (HBVr) when they receive immunosuppressive therapy. In this study, we aimed to evaluate the hepatitis B serology, risk groups and antiviral prophylaxis of patients receiving various immunosuppressive therapies due to rheumatological diseases.
Material and Method: The study included 375 patients over 18 years of age who received tumor necrosis factor-α (TNF-α) inhibitor, tyrosine kinase inhibitor, steroids, methotrexate or anti-CD20 antibodies due to rheumatic diseases in a training and research hospital between May 2022 and May 2023. Hepatitis B surface antigen (HbsAg), hepatitis B surface antibody (anti-Hbs), hepatitis B core protein antibody (anti-Hbc IgG) serologies, immunosuppressive therapies and oral antivirals were retrospectively analyzed.
Results: The average age of the 375 patients included in the study was 43.77±13.07 years. 193 (51.5%) of the patients were male. 11 patients were HbsAg positive, 150 patients were anti-Hbs positive, 19 patients were isolated anti-Hbc IgG positive, and 79 patients were both anti-Hbs and anti-Hbc IgG positive. According to serological findings, 109 (29%) patients had HBV exposure. All three test results of 194 (51.7%) patients were negative. A total of 85 (22.7%) patients received oral antiviral prophylaxis due to the use of immunosuppressive agents. In terms of HBVr, 16.5% were evaluated as high risk, 75.3% as moderate risk, and 8.2% as low risk. Out of 85 patients 79 received entecavir, 5 reveived tenofovir disoproxil fumarate (TDF) and 1 received tenofovir alafenamide fumarate (TAF). The mean duration for the immunosuppressive therapy was 6.41±4.20 years. The mean duration of oral antiviral prophylaxis among patients was 1.02±1.72 years. HBVr was not observed in any of our patients.
Conclusion: Before patients receive immunosuppressive therapy, hepatitis B serologies and prophylaxis indication should be evaluated firstly. In addition, as a preventive medicine activity, hepatitis B vaccinations of unvaccinated patients should be completed as quickly as possible.
Investigation of Variants In SARS-CoV-2 Infections after Three Doses of COVID-19 Vaccine
Authors: GÜRER GİRAY Burcu , GÜVEN AÇIK Gökçe 
Published: October 2023

Abstract
Objective: Our study focused on retrospectively assessing variant of concern, specified by the World Health Organization (WHO), with one-step reverse transcription and real-time polymerase chain reaction (RT-PCR) test in SARS-CoV-2 positive patients after three doses of attenuated COVID-19 vaccine.
Methods: 8.520 samples transported with viral nucleic acid buffer (vNAT) tubes between June 2021 and January 31, 2022, were tested and included in the study. All the patients whose samples were included in our research had 3 doses of CoronaVac (Sinovac Life Science Co, Ltd, Beijing, China). Gender distribution was 4686 (55%) female and 3834 ( 45%) males. Variant specific genome regions only found in B.1.351, P.1 and B.1.1.7 as well as ORF1ab and N gene regions are investigated by the Bio-Speedy® Emerging Plus kit (Bioeksen AR-GE Technologies, Turkey) used to identify the variants in the study.
Results: All 8.520 samples were SARS-CoV-2 RT-PCR positive. Our study detected alpha and delta variants in 1460 (17.14%) and 3570 (41.9%) patients respectively. 2570 (30.16%) patients did not have any variants according to test results. It was observed that the spread of beta, gamma and other suspicious variants remained at relatively low rates.
Conclusion: The delta variant became dominant from July until to the end of the year. Declining delta variant rates and increasing cases of suspected variants towards the beginning of December 2021 suggest the omicron variant. Therefore, molecular surveillance studies that are planned to take epidemiological data into consideration and to examine the prevalence and gene-based analysis of local and worldwide variants are required.
Assessment of DNA Damage Induced by Velum® Prime in Human Lymphocytes
Authors: TOĞAY Vehbi Atahan , AŞCI ÇELİK Dilek 
Published: October 2023

Aim: Fluopyram is a mitochondrial complex II inhibitor with low water solubility and a relatively long half-life in soil. So it may also be dangerous for humans. The effect of fluopyram on DNA damage was evaluated in human lymphocytes using the comet assay.
Materials and Methods: Lymphocytes of eight volunteers were isolated using histopaque-1077. Fluopyram was administered at doses of 0.05, 0.25, and 1.00 mg/mL for 1, 2, and 4 h. The comet assay was applied, and photographs of the slides were taken under a fluorescence microscope. 50 cells per slide were analyzed using the OpenComet software. The obtained results were statistically evaluated using one-way ANOVA.
Results: Fluopyram treatments at 1.00 mg/mL for 1 h and 0.05, 0.25, and 1.00 mg/mL for 2 and 4 h resulted in a statistically significant increase in DNA damage compared to the internal control groups (p
'What if I Die Before Him?' Concerns of Caregivers in Palliative Care
Authors: TUZ Canan , ÖZÇAKIR Alis 
Published: October 2023

Background/Aims: Caregivers are family members who provide unpaid assistance to their ill spouses. In Turkey, family caregiving, engagement, and support are needed when patients are hospitalized. This study aims to better understand the feelings of caregivers behind their behaviors in a terrier palliative care setting.
Methods: This research is a cross-sectional qualitative study designed with phenomenology. Five family caregivers who volunteered to participate were interviewed face-to-face. Inclusion criteria were adult informal caregivers who currently provided care to the patient at home and in the hospital.
Results: The family caregivers consist of five spouses with a mean age of 44.8 ± 4.80 years. Each caregiver is a female and the spouse of the patient. Of the patients diagnosis was Alzheimer’s disease, dementia, gastric cancer, and stroke, respectively. The caregiving time was approximately 2.79 ± 1.62 years. Four themes and eleven subthemes were indicated: Concerns about themselves: Overestimating their health care problems, Anxiety about staying strong; Consequences of the patient: Remembering the patient like a “hero”; Acceptance of the situation Fear of “finding him death” Challenges about caregiving Sacrificing from life Excessive responsibility Embarrassment from diaper care Lack of orientation for caregiving at first Coping strategies Devine providence Religious beliefs.
Conclusions: The findings of the study indicate that family caregivers have concerns about themselves and the consequences of their roles. Even if they try to cope with spirituality, healthcare providers can support them by recognizing their essential roles.
Outcomes of Low and Middle Income Children with Relapsed Acute Lymphoblastic Leukemia: Single-Center Experience
Authors: GUZELKUCUK Zeliha , ARMAN BİLİR Özlem , OK BOZKAYA İkbal , KAÇAR Dilek , ISİK Melek , GÜRLEK GÖKÇEBAY Dilek , ÖZBEK Namık Yaşar , YARALI Hüsniye Neşe 
Published: October 2023

Abstract
Aim: Despite numerous advances in treating acute lymphoblastic leukemia (ALL) in children, relapse continues to be the leading cause of mortality. This study aimed to analyze the data of patient’s characteristics, and outcomes of children with relapsed ALL.
Material and Method: We retrospectively analyzed the records of patients aged 1–18 years diagnosed with relapsed ALL between January 2004 and December 2018.
Results: 452 ALL patients followed up in the study period and 55 patients relapsed. The relap-se rate was 12.1%. Thirty-four (61.8%) of the relapsed patients were male. The median age was seven years (1–17 years). Forty-six patients (83.6%) had precursor B-cell ALL and nine pati-ents (16.3%) had T-cell ALL. The site of relapse was bone marrow in 41 patients (74.5%), and extramedullary (central nervous system, testis, or soft tissue) in 11 patients (20%). The mean duration from the initial diagnosis to relapse was 32 months ( min-max: 4 -108 months, SD±21.2) and 20 months (min-max: 7-38 months, SD± 11.1) in patients with B- cell ALL and T- cell ALL respectively. The median follow-up time was 39.8 months (min-max: 3–198 months, SD±44.5) from the initial diagnosis. Thirty-seven patients (67.3%) died. The 5-year overall survival rate was 41.6%. Recurrent relapse and progressive disease were the most com-mon causes of death. The mortality rate was significantly associated with the immunophenotype, treatment response on days 8, 15, and 33 of initial diagnosis, the risk group at initial diagnosis, the site of relapse, and hematopoietic stem cell transplantation (p
Evaluation of the Effect of Pelvic Types on Trans-Sacral Screw Corridor Diameter (Retrospective Analysis Using Computerized Tomography Data)
Authors: KARATEKİN Yavuz Selim , BALTA Orhan 
Published: October 2023

Aims: The aim of this study was to investigate the effect of pelvis type on the trans-sacral(TS) screw corridor diameter.
Methods: Pelvis computed tomography (CT) scans between 2017 and 2020 were retrospectively reviewed. Age, gender, height, weight and body mass index (BMI) of the patients were determined during the CT examination. Pelvic CT scans were examined using the imaging system's multi-plane reconstruction (MPR) mode, and the TS screw corridor was measured for both the upper and second sacral segments. In addition, pelvic incidence (PI), sacral tilt (SS), and pelvic tilt (PT) values were measured. Pelvis typing was performed using the large transverse diameter, anteroposterior diameter, interspinous, intertuberocytosis, transverse outlet diameter, sagittal mid-pelvic diameter, and sagittal outlet values.
Results: 81(38%) male and 132(62%) female patients were included in the study. Gynecoid pelvis type was more common in females and android pelvis in males (p < 0.001). The largest diameters in the TS screw corridor at the S1 level belonged to the anthropoid pelvis type. However, in the TS corridor at the S2 level, there was a significant difference between the pelvis-type groups in the mean values of AP and CC (p < 0.001). The effect of gender difference on the TS screw corridor width at the S1 and S2 levels was significant. An adequate corridor width for the TS screw corridor was detected in 50.8% of females and 67.9% of males at the S1 level, while in 21.2% of females and 70.4% of males at the S2 level.
Conclusions: There is a significant difference in the dimensions of the trans-sacral screw corridor according to the pelvis type and gender, with the largest diameter observed in the anthropoid pelvis type and males. In critical situations, especially in males and individuals with android-anthropoid pelvis, the trans-sacral screw option should be considered primarily not only for the S1 trans-sacral corridor but also for the S2 trans-sacral corridor in pelvic posterior ring injuries
Dynamic thiol/disulphide homeostasis and ischemic modified albumin levels in idiopathic polyhydramnios
Authors: ÖZGÜRLÜK İzzet , SAHİN Dilek 
Published: October 2023

Objective: The aim of study was to determine whether idiopathic polyhydramnios is in relation with dynamic thiol-disulfide homeostasis and ischemia modified albumin levels or not.
Materials and methods: In this prospective case- control study, a total of 126 participants were included. The patient group consisted of 56 patients who were diagnosed idiopathic polyhydramnios, and the control group consisted of 56 healthy normal pregnant. Native thiol (-SH), total thiol (-SH. -SS), dynamic disulfide (-SS), values from maternal serum were measured and compared between groups.
Results: 112 patients aged between 18-35 years, consisting of 56 idiopathic polyhydramnios and 56 control groups were included in the study. Maternal serum native and total thiol values were significantly higher in study group compared to control group (382.2 ±78.5 mmol/L vs. 331.8 ±43.9 mmol/L, p
Knowledge level about HPV infection and cervical cancer screening tests
Authors: ALDIKAÇTIOĞLU TALMAÇ Merve , VURAL Nazlı Aylin , SATILMIŞOĞLU Zeliha Zeynep , HOCAGİL Füreya Zilal , ATASOY RUSEN Merve , ÇETİNKAYA Nilüfer 
Published: October 2023

Introduction: Understanding HPV and cervical cancer is vital for prevention, early diagnosis, and treatment. Nurses play a crucial role in implementing screening and are also at risk. This study examines nurses' knowledge and practices regarding HPV and cervical cancer screening in a tertiary center.
Materials and Methods: It is a prospective survey study conducted with nurses. A total of 191 nurses participated in the three-part and 53-item survey that evaluated demographic data, HPV knowledge levels and cervical cancer screening awareness.
Results: A total of 2895 nurses work at the hospital. The rate of participation in the research was 6.6% with 191 participants. The average age of the participants is 27.1. Majority of the participants are female (n: 171, 89.5%), only 20 (10.5%) are male. While 81.9% of the respondents had knowledge about sexually transmitted diseases, only 13.5% had gone to regular gynecological examinations. Despite 98.4% of the participants who had knowledge about cervical cancer and screening practices, only 11% (n:19) had undergone cervical cancer screening and 94.2% (n:180) had not received HPV vaccine. The most mis-answered question about HPV was whether current vaccines protect against both genital warts and cervical cancer.
Conclusion: In conclusion, nurses' knowledge level and screening practices about HPV and cervical cancer need to be improved. It is also important to increase awareness of the HPV vaccine and encourage more people to receive it. This effort could positively impact health outcomes related to cervical cancer and HPV.
A Systematic Review and Meta-Analysis: Acute Migraine Treatment in Pediatric and Adolescent Populations
Authors: ÖZDEMİR KAÇER Emine , ATEŞ Can 
Published: October 2023

Backgrounds: The array of medications used to treat acute migraine in adults is extensive, with several now authorized for use in children and adolescents in outpatient settings.
Aims: The aim of this meta-analysis was to evaluate the impact of pharmacological interventions, regardless of the method of delivery, compared to placebo, in treating migraine among individuals aged 18 years or younger.
Materials and Methods: We searched PubMed, EMBASE, and Cochrane Library for comparative RCTs published 30 years before May 2023. We included prospective randomized controlled clinical trials of children and adolescents with migraine, comparing acute symptom-relieving migraine medications with a placebo.
Results: Twelve clinical trials were included in this meta-analysis. The migraine treatment choice and the proportion of patients with complete pain relief at 2 hours post-treatment were analyzed. Ibuprofen (n=2), sumatriptan (n=3), zolmitriptan (n=3), and rizatriptan (n=4) were used for the analysis. Notably, sumatriptan did not exhibit significant differences compared to placebo, despite mixed individual study outcomes (OR:1.35; 95% CI 0.81, 2.27). Rizatriptan displayed varying efficacies across age groups, showing no significant difference in adolescents aged 12-17 years (p>0.05). Zolmitriptan showed dose-dependent effectiveness, with higher doses yielding better outcomes (OR:2.18; 95% CI 1.45,3.28). Ibuprofen emerged as the sole non-triptan medication to demonstrate efficacy in achieving pain-free status at 2 hours, with a favorable safety profile (OR:2.54; 95% CI 1.20, 5.37).
Conclusion: These findings suggest that ibuprofen, zolmitriptan, and rizatriptan are potential treatment options for rapidly relieving migraine in children and adolescents. However, ibuprofen may have advantages over triptans, owing to its convenience and cost-effectiveness.
Comparison of Results of the sIPOM and the IPOM-Plus Techniques for Small and Medium-Sized Primary Midline Abdominal Wall Hernias
Authors: TAŞDELEN Halil Afşin 
Published: October 2023

Abstract

Aims: To compare the results of the standard intraperitoneal onlay mesh (sIPOM) and intraperitoneal onlay mesh-plus (IPOM-Plus) techniques for the repair of small and medium-sized primary midline abdominal wall hernias (PMAWHs).
Material and Method: A prospectively documented data of 82 patients who underwent the sIPOM and IPOM-Plus approach between January 2016 and December 2021 was retrospectively evaluated. Forty-one patients with PMAWH repaired with sIPOM (18) and IPOM-Plus (23) were included in the study. Median follow-up for the sIPOM and IPOM-Plus was 73 and 51 months (mean 73.83±7.81vs. 47.43±19.22), respectively.
Results: Both groups had no difference in demographics, comorbidities, and smoking habits. The mesh area (MA) and the mesh-to-defect ratio (MDR) were not significant (p=0.083 and p= 0.30, respectively); however, the defect area (DA) was higher in the sIPOM group (p= 0.005). The IPOM-Plus group had a longer operative time and length of hospital stay (LOHS) and higher early postoperative pain than the IPOM group (p = 0.002, p = 0.049 and p
Breast Cancer Awareness Among Women Patients of a Private Hospital: A Cross-Sectional Study on Risk Factors, Symptoms, and Attitudes in Turkey
Authors: KAYIKÇIOĞLU Hatice 
Published: October 2023

Background/Aims: The global prevalence of breast cancer continues to rise, necessitating heightened awareness, early detection, and effective management strategies. This study aimed to assess differences in breast cancer awareness, risk factors, symptoms, and attitudes among economically well-off female patients in Turkey.
Material and Methods: A single-center survey was conducted at a private hospital, involving 189 economically well-off patients. Descriptive statistics, Chi-square tests, ANOVA, and Kruskal-Wallis tests were used for data analysis.
Results: Participants had a mean age of 50.2 years, with the highest awareness of risk factors and symptoms observed in the 31-50 age group. Marital status and education were associated with breast cancer awareness, risk factors, symptoms, and screening methods. Education level correlated with enhanced knowledge of risk factors and symptoms. The prevalence of breast cancer risk awareness was 41.2%, with the most recognized risk factors being smoking and family history. Palpable lump (36.4%) and redness of breast skin (16.9%) were identified as common symptoms. Screening methods included self-breast examination (12.2%), physician examination (13.2%), ultrasonography (19%), magnetic resonance imaging (15.9%), and mammography (23.3%).
Discussion: Breast cancer remains a critical global health concern, necessitating increased awareness and early detection. In Turkey, breast cancer poses a significant health burden. Socioeconomic factors impact awareness and outcomes, with education and marital status influencing awareness levels. The study highlights the need for tailored interventions and accessible screening programs to enhance awareness and early detection.
Conclusion: This study sheds light on breast cancer awareness and attitudes among economically well-off female patients in Turkey. Education, marital status, and age play pivotal roles in shaping awareness levels. Targeted interventions and education are crucial for improving early detection, reducing mortality rates, and effectively addressing breast cancer.
Evaluation of Neurofibromatosis Type 1 Associated Optic Pathway Gliomas
Authors: VURAL Özge , OKUR Arzu , PINARLI Faruk Güçlü 
Published: October 2023

Background/Aims: Optic pathway gliomas (OPGs) are low-grade gliomas histologically represented by pilocytic astrocytoma (PA) in 90% of cases, can develop from any part of the visual pathways such as optic nerve, chiasm, optic tract, or optic radiations which frequently involve the hypothalamus. OPGs account for 3–5% of childhood central nervous system (CNS) tumors and about 2% of pediatric glial lesions. OPGs are believed to be the most prevalent intracranial tumor in patients with neurofibromatosis type 1 (NF-1) and can occur in 15–20% of NF-1 cases. The aim of this study is to evaluate the clinical features and treatment response in patients diagnosed with optic glioma and NF-1.
Methods: All cases diagnosed with OPG and received treatment in the Pediatric Oncology Department, between January 2015 to January 2021 were retrospectively evaluated. Inclusion criteria include children and adolescents with OPG aged between 0 and 18 years. The medical records (gender, age, tumor entity, tumor location) of patients, as well as their treatment history and magnetic resonance imaging (MRI) scans, were examined. The diagnosis of OPG was made clinically and radiologically by the tumor board. The recommendations of the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group were used in the diagnosis and evaluation of treatment response. Patients received intravenous chemotherapy with SIOP LGG 2004 (vincristine- carboplatin) with or without bevacizumab (10 mg/kg, started every 2 weeks), therapy or vinblastine (3 mg/m2, weekly).
Results: This study included 27 cases during the study period from January 2015 to January 2021. In this study there were 14 male (51.8 %) and 13 female (48.1 %) patients. The median age was 4.8 (range: 0.5–14.9) years. Biopsy was performed in three patients and the diagnosis was low-grade glioma (pilocytic astrocytoma) for all of them. Chemotherapy was administered to 22 cases in total. Twelve patients received vincristine-carboplatine, 5 patients received vincristine-carboplatin with bevacizumab and 5 patients received vinorelbine. Radiological response was evaluated in all 22 patients at 3 months MRI. No patient had a radiological complete respons, 11 patients (50%) had partial response, 2 patients (9%) presented with a progressive disease, showing an increase in measurements of 35% and 9 patients(40.9%) had stable disease at the 3-month evaluation.
Conclusions: Systemic and visual problems play a significant role in the selection of treatment for pediatric patients with optic gliomas. An essential treatment option for improving symptoms and reducing tumor size is systemic chemotherapy. A crucial therapy option for enhancing vision is bevacizumab for the patients with NF-associated OPG.
An Investigation into the Assessment of Nutritional Status, Quality of Life, and Adherence to the Mediterranean Diet among Women Affected by Breast Cancer
Authors: ÇAPALI ŞAHİN Yekta , YILMAZ Sine 
Published: October 2023

Aim: The aim of this study is to assess the quality of life and adherence to the Mediterranean diet (MD) among female breast cancer patients.
Material and Method: The study included a cohort of 120 women who received a breast cancer diagnosis within the last year. Anthropometric measurements were conducted, and body composition analysis was carried out to determine body fat percentage. The Mediterranean Diet Adherence Scale (MEDAS) and the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30) were employed for data collection.
Results: A total of 120 breast cancer patients, with an average age of 49.8±10.56 years, were enrolled in the study. Among these participants, 42.5% were categorized as having a normal weight. The mean waist circumference and waist/hip ratio were 94.6±12.20 cm and 0.87±0.10, respectively. Body fat percentages were determined to be 36.8±8.61%. The average total energy intake was 1944.9±385.24 kcal, with the percentage of total fat intake from energy averaging at 35.6±4.81%. Patients had a mean body mass index (BMI) of 29.0±5.80 kg/m², with 40.8% of them classified as obese. The mean MEDAS score was 7.3±2.65, and the EORTC QLQ-C30 score averaged at 69.7±11.94. There is a negative correlation was found between BMI, waist circumference and MEDAS score; A positive correlation was found between MEDAS scores and EORTC scores.
Conclusion: Breast cancer patients with high compliance with the Mediterranean diet have a higher quality of physical, emotional and social life. Therefore, evaluation of modifiable risk factors in breast cancer patients is essential for the prognosis of the disease.